Myeloma Canada is a non-profit, charitable organization created by, and for people impacted by multiple myeloma, a relatively unknown cancer of the plasma cells. Exclusively devoted to the Canadian myeloma community, Myeloma Canada has been making myeloma matter since 2005. As a patient-driven, patient-focused grassroots organization, Myeloma Canada drives collaborative efforts to unify the voice of the community to effectively shape the Canadian treatment landscape with a committed focus on the improvement of patient outcomes.
- GSK provided a conference sponsorship of $30,000 for the Multiple Myeloma Research Network Round table
- GSK provided core funding of $10,000 for 2019 initiatives
Our support represented less than 2% of their overall income.